Craig Balog

1.1k total citations · 1 hit paper
11 papers, 736 citations indexed

About

Craig Balog is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Craig Balog has authored 11 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Craig Balog's work include Acute Myocardial Infarction Research (6 papers), Coronary Interventions and Diagnostics (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Craig Balog is often cited by papers focused on Acute Myocardial Infarction Research (6 papers), Coronary Interventions and Diagnostics (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Craig Balog collaborates with scholars based in United States, Australia and United Kingdom. Craig Balog's co-authors include E. Murat Tuzcu, Stephen J. Nicholls, Timothy D. Crowe, Paul Schoenhagen, A. Michael Lincoff, James E. Tcheng, Eric J. Topol, Leslie Cho, Steven E. Nissen and Steven E. Nissen and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

Craig Balog

11 papers receiving 703 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

2022 209 citations Steven E. Nissen, Kathy Wolski et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig Balog United States	10	486	478	154	97	80	11	736
Mitsuaki Endo Japan	13	439 0.9×	357 0.7×	297 1.9×	73 0.8×	135 1.7×	34	709
Jum Suk Ko South Korea	16	420 0.9×	378 0.8×	228 1.5×	33 0.3×	124 1.6×	65	726
Ayşe Saatçı Yaşar Türkiye	16	555 1.1×	354 0.7×	169 1.1×	74 0.8×	159 2.0×	51	826
J R Hangartner United Kingdom	6	525 1.1×	390 0.8×	265 1.7×	35 0.4×	114 1.4×	6	809
Ikuyoshi Kusama Japan	12	363 0.7×	268 0.6×	229 1.5×	36 0.4×	46 0.6×	17	546
Yun‐Hyeong Cho South Korea	9	210 0.4×	363 0.8×	67 0.4×	68 0.7×	50 0.6×	29	519
Maria Borentain France	10	566 1.2×	332 0.7×	140 0.9×	27 0.3×	59 0.7×	16	687
Neeraj Tandon United States	9	307 0.6×	276 0.6×	93 0.6×	22 0.2×	81 1.0×	20	548
Byoung‐Joo Choi South Korea	15	542 1.1×	382 0.8×	390 2.5×	45 0.5×	98 1.2×	53	838
Nevin C. Baker United States	13	413 0.8×	434 0.9×	88 0.6×	33 0.3×	173 2.2×	38	698

Countries citing papers authored by Craig Balog

Since Specialization

Citations

This map shows the geographic impact of Craig Balog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Balog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Balog more than expected).

Fields of papers citing papers by Craig Balog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Balog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Balog. The network helps show where Craig Balog may publish in the future.

Co-authorship network of co-authors of Craig Balog

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Balog. A scholar is included among the top collaborators of Craig Balog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Balog. Craig Balog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Nissen, Steven E., Kathy Wolski, Craig Balog, et al.. (2022). Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels. JAMA. 327(17). 1679–1679. 209 indexed citations breakdown →

Kataoka, Yu, Kathy Wolski, Craig Balog, et al.. (2014). Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques. European Heart Journal - Cardiovascular Imaging. 15(9). 1035–1041. 19 indexed citations

Bayturan, Özgür, E. Murat Tuzcu, Stephen J. Nicholls, et al.. (2009). Attenuated Plaque at Nonculprit Lesions in Patients Enrolled in Intravascular Ultrasound Atherosclerosis Progression Trials. JACC: Cardiovascular Interventions. 2(7). 672–678. 24 indexed citations

Sipahi, İlke, E. Murat Tuzcu, Katherine E. Wolski, et al.. (2007). β-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials. Annals of Internal Medicine. 147(1). 10–18. 67 indexed citations

Sipahi, İlke, E. Murat Tuzcu, Paul Schoenhagen, et al.. (2006). Effects of Normal, Pre-Hypertensive, and Hypertensive Blood Pressure Levels on Progression of Coronary Atherosclerosis. Journal of the American College of Cardiology. 48(4). 833–838. 131 indexed citations

Blankenship, James C., Craig Balog, A. Michael Lincoff, et al.. (2002). Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). The American Journal of Cardiology. 90(9). 916–921. 28 indexed citations

Mazur, Wojciech, Grzegorz L. Kałuża, Shelly Sapp, et al.. (2002). Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: Lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. American Heart Journal. 143(4). 594–601. 4 indexed citations

Blankenship, James C., Craig Balog, Shelly Sapp, et al.. (2002). Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials. Catheterization and Cardiovascular Interventions. 57(4). 476–483. 16 indexed citations

Cho, Leslie, Eric J. Topol, Craig Balog, et al.. (2000). Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender. Journal of the American College of Cardiology. 36(2). 381–386. 101 indexed citations

10.

McErlean, Ellen, et al.. (2000). Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. The American Journal of Cardiology. 85(4). 421–426. 33 indexed citations

11.

Lincoff, A. Michael, James E. Tcheng, Robert M. Califf, et al.. (1999). Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab. Circulation. 99(15). 1951–1958. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact